Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study
Walter Stummer(University of Münster), Uwe Pichlmeier(Medac (Germany)), Andrea Bink(University of Zurich), Kea Franz(Goethe University Frankfurt), Claudia Goetz, Ulf Nestler(Leipzig University), Jörg‐Christian Tonn(Goethe University Frankfurt), H. Maximilian Mehdorn(University Hospital Schleswig-Holstein)
Cited by 300
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k